Judge Tosses EPO Fraudulent Marketing Suit Against Amgen
This article was originally published in The Pink Sheet Daily
Executive Summary
A California court says third party payers did not show that Amgen fraudulently misrepresented the effectiveness of Epogen and Aranesp.